SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 02, 2023
March 2, 2023
 · 
1 min read
Genetown
Astria Therapeutics Presents Additional Data Supporting STAR-0215 Profile as a Long-Acting Preventative Therapy for Hereditary Angioedema at the 2023 American Academy of Allergy, Asthma, and Immunology Annual Meeting
February 24, 2023
 · 
7 min read
Genetown
Astria Therapeutics to Present New STAR-0215 Data at the 2023 American Academy of Allergy, Asthma, and Immunology Annual Meeting
February 21, 2023
 · 
6 min read
Drug Development
Astria Therapeutics Initiates ALPHA-STAR Phase 1b/2 Clinical Trial of STAR-0215 in People with HAE
February 8, 2023
 · 
7 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 02, 2023
February 2, 2023
 · 
1 min read
Genetown
Astria Therapeutics Announces Closing of Underwritten Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 19, 2022
 · 
2 min read
Deals
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
December 15, 2022
 · 
4 min read
Drug Development
Astria Therapeutics Announces Positive Preliminary Results from the Phase 1a Clinical Trial of STAR-0215 in Healthy Subjects
December 15, 2022
 · 
8 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 02, 2022
December 2, 2022
 · 
1 min read
Business
Astria Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
November 10, 2022
 · 
11 min read
Load More